[3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate

C35H40F2N8O10 — CID 137030974

IUPAC[3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate
SMILESCC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc(CN3CCN(C(=O)CCOC(=O)Nc4ccn(C5OC(CO)C(O)C5(F)F)c(=O)n4)CC3)cc2)c(O)cc1O
InChIInChI=1S/C35H40F2N8O10/c1-19(2)22-15-23(25(48)16-24(22)47)30-40-41-33(52)45(30)21-5-3-20(4-6-21)17-42-10-12-43(13-11-42)28(49)8-14-54-34(53)39-27-7-9-44(32(51)38-27)31-35(36,37)29(50)26(18-46)55-31/h3-7,9,15-16,19,26,29,31,46-48,50H,8,10-14,17-18H2,1-2H3,(H,41,52)(H,38,39,51,53)
InChIKeyGSUPSQCYCRQLCR-UHFFFAOYSA-N
MW770.75 g/mol
LogP1.49
Rot. Bonds11

About [3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate

[3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate (PubChem CID 137030974) has the molecular formula C35H40F2N8O10 and a molecular weight of 770.75 g/mol. Its IUPAC name is [3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate.

Molecular Properties

Compound Name[3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate
PubChem CID137030974
Molecular FormulaC35H40F2N8O10
Molecular Weight770.75 g/mol
Exact Mass770.28
IUPAC Name[3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate
SMILESCC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc(CN3CCN(C(=O)CCOC(=O)Nc4ccn(C5OC(CO)C(O)C5(F)F)c(=O)n4)CC3)cc2)c(O)cc1O
InChIInChI=1S/C35H40F2N8O10/c1-19(2)22-15-23(25(48)16-24(22)47)30-40-41-33(52)45(30)21-5-3-20(4-6-21)17-42-10-12-43(13-11-42)28(49)8-14-54-34(53)39-27-7-9-44(32(51)38-27)31-35(36,37)29(50)26(18-46)55-31/h3-7,9,15-16,19,26,29,31,46-48,50H,8,10-14,17-18H2,1-2H3,(H,41,52)(H,38,39,51,53)
InChIKeyGSUPSQCYCRQLCR-UHFFFAOYSA-N
XLogP1.49
TPSA237.60 Ų
H-Bond Donors6
H-Bond Acceptors15
Rotatable Bonds11
Heavy Atoms55
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500770.75
LogP ≤ 51.49
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1015

Analyze [3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate?
The IUPAC name of [3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate (CID 137030974) is [3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate.
What is the SMILES notation for [3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate?
The canonical SMILES for [3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate is CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc(CN3CCN(C(=O)CCOC(=O)Nc4ccn(C5OC(CO)C(O)C5(F)F)c(=O)n4)CC3)cc2)c(O)cc1O.
What is the InChIKey of [3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate?
The InChIKey is GSUPSQCYCRQLCR-UHFFFAOYSA-N. The full InChI is InChI=1S/C35H40F2N8O10/c1-19(2)22-15-23(25(48)16-24(22)47)30-40-41-33(52)45(30)21-5-3-20(4-6-21)17-42-10-12-43(13-11-42)28(49)8-14-54-34(53)39-27-7-9-44(32(51)38-27)31-35(36,37)29(50)26(18-46)55-31/h3-7,9,15-16,19,26,29,31,46-48,50H,8,10-14,17-18H2,1-2H3,(H,41,52)(H,38,39,51,53).
What are the key properties of [3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate?
[3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate has a molecular weight of 770.75 g/mol, XLogP of 1.49, 11 rotatable bonds, 6 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for [3-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazin-1-yl]-3-oxopropyl] N-[1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate is sourced from PubChem (CID 137030974), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).